Clinical Trials Browser

Terminated × Erlotinib Hydrochloride × Dermatologic × Clear all

NCT01059305 2017-04-04

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Phase 2 Terminated

10 enrolled 2 charts

Skin Neoplasms